Agency for Medicinal Products and Medical Devices of the Republic of Slovenia
The updated EURIPID Guidance Document on External Reference Pricing (ERP) provides practical, evidence-based insights for policymakers across Europe. A key milestone of the EURIPID ACCESS project has been the update […]
What makes an effective External Reference Pricing system today? Read More »
JAMS 2.0 project aims to reinforce the market surveillance of medical devices (MD) and in-vitro medical devices (IVD) in EU/EEA Member States to harmonize approaches in this field across the
JAMS 2.0: Report on joint inspections campaign of medical device manufacturers Read More »
As part of the Joint Action “Supporting the increased capacity and competence building of the EU medicines regulatory network” (IncreaseNET), funded under the EU4Health programme 2021–2027, the Italian Medicines Agency
call for expressions of interest Read More »
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP), as the leader of Work Package 4 Sustainability within the EU4Health joint action Reinforced Market Surveillance of
Sustainability workshop of JAMS 2.0 outcomes Read More »
Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP) hosted members of the European Integrated Price Information Database (EURIPID) on May 13 and 14, 2025. The
Meeting of Members of the European Integrated Price Information Database (EURIPID) Read More »
Since its launch on January 1, 2024, IncreaseNET has been dedicated to strengthening collaboration, knowledge-sharing, and training within the European Medicines Regulatory Network (EMRN). Over the past year, the project
IncreaseNET: A One-Year Progress Overview Read More »
The CHESSMEN project has reached month 24. A summary of the main activities carried out in 2024 can be found at this link.
CHESSMEN Joint Action Wrap-Up 2024 Read More »
